Lineage Cell Therapeutics Overview

Lineage Cell Therapeutics Profit Margin

Profitability ratio analysis for LCTX.

Quarterly Profit Margin

-278.96%

↓ 1.23% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-434.44%

↓ 156.20% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin